This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Anis S, Khan MA, Fatima A, Kanani F, Aijaz J, Hussain A, Sarfaraz S. Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients – a single-centered study from Pakistan. Immunol Res. 2023 Dec;71(6):941–949. https://doi.org/10.1007/s12026-023-09407-yAnisSKhanMAFatimaAKananiFAijazJHussainASarfarazS. Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients – a single-centered study from Pakistan. . 2023Dec;71(6):941–949. https://doi.org/10.1007/s12026-023-09407-ySearch in Google Scholar
Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, et al; SARS CoV-2 Rapid Response Team of Pasteur Institute of Iran (PII). Severe acute respiratory syndromecoronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects. Rev Med Virol. 2021 May;31(3):e2183. https://doi.org/10.1002/rmv.2183ArashkiaAJalilvandSMohajelNAfchangiAAzadmaneshKSalehi-VaziriMFazlalipourMPouriayevaliMHJalaliTMousaviNasabSDet al.; SARS CoV-2 Rapid Response Team of Pasteur Institute of Iran (PII). Severe acute respiratory syndromecoronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects. . 2021May;31(3):e2183. https://doi.org/10.1002/rmv.2183Search in Google Scholar
Arkhipova-Jenkins I, Helfand M, Armstrong C, Gean E, Anderson J, Paynter RA, Mackey K. Antibody response after SARS-CoV-2 infection and implications for immunity: A rapid living review. Ann Intern Med. 2021 Jun;174(6):811–821. https://doi.org/10.7326/M20-7547Arkhipova-JenkinsIHelfandMArmstrongCGeanEAndersonJPaynterRAMackeyK. Antibody response after SARS-CoV-2 infection and implications for immunity: A rapid living review. . 2021Jun;174(6):811–821. https://doi.org/10.7326/M20-7547Search in Google Scholar
Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT, Cohen JI. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J Infect Dis. 2020 Jun;222(2):206–213. https://doi.org/10.1093/infdis/jiaa273BurbeloPDRiedoFXMorishimaCRawlingsSSmithDDasSStrichJRChertowDSDaveyRTCohenJI. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. . 2020Jun;222(2):206–213. https://doi.org/10.1093/infdis/jiaa273Search in Google Scholar
Cacaci M, Menchinelli G, Ricci R, De Maio F, Mariotti M, Torelli R, Morandotti GA, Bugli F, Sanguinetti M, Posteraro B. Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay. Clin Microbiol Infect. 2021 Jan;27(5):808–810. https://doi.org/10.1016/j.cmi.2020.12.014CacaciMMenchinelliGRicciRDeMaioFMariottiMTorelliRMorandottiGABugliFSanguinettiMPosteraroB. Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay. . 2021Jan;27(5):808–810. https://doi.org/10.1016/j.cmi.2020.12.014Search in Google Scholar
Casian JG, Angel AN, Lopez R, Bagos C, MacMullan MA, Bui ML, Chellamathu P, Das S, Turner F, Slepnev V, et al. Saliva-based ELISAs for effective SARS-CoV-2 antibody monitoring in vaccinated individuals. Front Immunol. 2021 Sep;12:701411. https://doi.org/10.3389/fimmu.2021.701411CasianJGAngelANLopezRBagosCMacMullanMABuiMLChellamathuPDasSTurnerFSlepnevVet al.Saliva-based ELISAs for effective SARS-CoV-2 antibody monitoring in vaccinated individuals. . 2021Sep;12:701411. https://doi.org/10.3389/fimmu.2021.701411Search in Google Scholar
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021 Feb;147(2):545–557.e9. https://doi.org/10.1016/j.jaci.2020.10.040CerviaCNilssonJZurbuchenYValapertiASchreinerJWolfensbergerARaeberMEAdamoSWeigangSEmmeneggerMet al.Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. . 2021Feb;147(2):545–557.e9. https://doi.org/10.1016/j.jaci.2020.10.040Search in Google Scholar
De-Simone SG, Napoleão-Pêgo P, Lechuga GC, Carvalho JPRS, Monteiro ME, Morel CM, Provance DW Jr. Mapping IgA epitope and cross-reactivity between severe acute respiratory syndrome-associated coronavirus 2 and DENV. Vaccines (Basel). 2023 Nov;11(12):1749. https://doi.org/10.3390/vaccines11121749De-SimoneSGNapoleão-PêgoPLechugaGCCarvalhoJPRSMonteiroMEMorelCMProvanceDWJr. Mapping IgA epitope and cross-reactivity between severe acute respiratory syndrome-associated coronavirus 2 and DENV. . 2023Nov;11(12):1749. https://doi.org/10.3390/vaccines11121749Search in Google Scholar
Drummer HE, Van H, Klock E, Zheng S, Wei Z, Boo I, Center RJ, Li F, Bhat P, Ffrench R, et al. Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection. medRxiv [Preprint]. 2021 Jul 1:2021. 06.28.21259671. https://doi.org/10.1101/2021.06.28.21259671DrummerHEVanHKlockEZhengSWeiZBooICenterRJLiFBhatPFfrenchRet al.Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection. . 2021Jul1:2021. 06.28.21259671. https://doi.org/10.1101/2021.06.28.21259671Search in Google Scholar
Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. 2020 Jul;26(7):771–783. https://doi.org/10.1261/rna.076232.120EsbinMNWhitneyONChongSMaurerADarzacqXTjianR. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. . 2020Jul;26(7):771–783. https://doi.org/10.1261/rna.076232.120Search in Google Scholar
Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdot-tir K, Holm H, Eythorsson E, Arnthorsson AO, Helgason D, Bjarnadottir K, Ingvarsson RF, et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med. 2020 Oct;383(18):1724–1734. https://doi.org/10.1056/NEJMoa2026116GudbjartssonDFNorddahlGLMelstedPGunnarsdot-tirKHolmHEythorssonEArnthorssonAOHelgasonDBjarnadottirKIngvarssonRFet al.Humoral immune response to SARS-CoV-2 in Iceland. . 2020Oct;383(18):1724–1734. https://doi.org/10.1056/NEJMoa2026116Search in Google Scholar
Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 Jul;71(15):778–785. https://doi.org/10.1093/cid/ciaa310GuoLRenLYangSXiaoMChangDYangFDelaCruzCSWangYWuCXiaoYet al.Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). . 2020Jul;71(15):778–785. https://doi.org/10.1093/cid/ciaa310Search in Google Scholar
Harley K, Gunsolus IL. Comparison of the clinical performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elec-sys Total SARS-CoV-2 antibody assays. J Clin Microbiol. 2020 Dec;59(1):10.1128/jcm.02104-20. https://doi.org/10.1128/jcm.02104-20HarleyKGunsolusIL. Comparison of the clinical performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elec-sys Total SARS-CoV-2 antibody assays. . 2020Dec;59(1): 10.1128/jcm.02104-20. https://doi.org/10.1128/jcm.02104-20Open DOISearch in Google Scholar
Herroelen PH, Martens GA, De Smet D, Swaerts K, Decavele AS. Humoral immune response to SARS-CoV-2: Comparative clinical performance of seven commercial serology tests. Am J Clin Pathol. 2020 Oct;154(5):610–619. https://doi.org/10.1093/ajcp/aqaa140HerroelenPHMartensGADeSmetDSwaertsKDecaveleAS. Humoral immune response to SARS-CoV-2: Comparative clinical performance of seven commercial serology tests. . 2020Oct;154(5):610–619. https://doi.org/10.1093/ajcp/aqaa140Search in Google Scholar
Hou H, Wang T, Zhang B, Luo Y, Mao L, Wang F, Wu S, Sun Z. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin Transl Immunology. 2020 May;9(5):e01136. https://doi.org/10.1002/cti2.1136HouHWangTZhangBLuoYMaoLWangFWuSSunZ. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. . 2020May;9(5):e01136. https://doi.org/10.1002/cti2.1136Search in Google Scholar
Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004 Dec;10(12):1062–1066. https://doi.org/10.1111/j.1469-0691.2004.01009.xHsuehPRHuangLMChenPJKaoCLYangPC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. . 2004Dec;10(12):1062–1066. https://doi.org/10.1111/j.1469-0691.2004.01009.xSearch in Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXet al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. . 2020Feb;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5Search in Google Scholar
Infantino M, Manfredi M, Grossi V, Lari B, Fabbri S, Benucci M, Fortini A, Damiani A, Mobilia EM, Panciroli M, et al. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 Mar;93(3):1436–1442. https://doi.org/10.1002/jmv.26422InfantinoMManfrediMGrossiVLariBFabbriSBenucciMFortiniADamianiAMobiliaEMPanciroliMet al.Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. . 2021Mar;93(3):1436–1442. https://doi.org/10.1002/jmv.26422Search in Google Scholar
Jääskeläinen AJ, Kekäläinen E, Kallio-Kokko H, Mannonen L, Kortela E, Vapalahti O, Kurkela S, Lappalainen M. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Euro Surveill. 2020 May;25(18):2000603. https://doi.org/10.2807/1560-7917.ES.2020.25.18.2000603JääskeläinenAJKekäläinenEKallio-KokkoHMannonenLKortelaEVapalahtiOKurkelaSLappalainenM. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. . 2020May;25(18):2000603. https://doi.org/10.2807/1560-7917.ES.2020.25.18.2000603Search in Google Scholar
Jalkanen P, Pasternack A, Maljanen S, Melén K, Kolehmainen P, Huttunen M, Lundberg R, Tripathi L, Khan H, Ritvos MA, et al. A Combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. J Infect Dis. 2021 Jul;224(2):218–228. https://doi.org/10.1093/infdis/jiab222JalkanenPPasternackAMaljanenSMelénKKolehmainenPHuttunenMLundbergRTripathiLKhanHRitvosMAet al.A Combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. . 2021Jul;224(2):218–228. https://doi.org/10.1093/infdis/jiab222Search in Google Scholar
Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 Nov;130(11):6141–6150. https://doi.org/10.1172/JCI142004KleinSLPekoszAParkHSUrsinRLShapiroJRBennerSELittlefieldKKumarSNaikHMBetenbaughMJet al.Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. . 2020Nov;130(11):6141–6150. https://doi.org/10.1172/JCI142004Search in Google Scholar
Korte W, Buljan M, Rösslein M, Wick P, Golubov V, Jentsch J, Reut M, Peier K, Nohynek B, Fischer A, et al. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. J Infect. 2021 Jan;82(1):e11–e14. https://doi.org/10.1016/j.jinf.2020.08.032KorteWBuljanMRössleinMWickPGolubovVJentschJReutMPeierKNohynekBFischerAet al.SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. . 2021Jan;82(1):e11–e14. https://doi.org/10.1016/j.jinf.2020.08.032Search in Google Scholar
Li D, Li J. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. J Clin Microbiol. 2021 Apr;59(5):10.1128/jcm. 02160-20. https://doi.org/10.1128/jcm.02160-20LiDLiJ. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. . 2021Apr;59(5): 10.1128/jcm. 02160-20. https://doi.org/10.1128/jcm.02160-20Search in Google Scholar
Li N, Wang P, Wang X, Geng C, Chen J, Gong Y. Molecular diagnosis of COVID-19: Current situation and trend in China (Review). Exp Ther Med. 2020 Nov;20(5):13. https://doi.org/10.3892/etm.2020.9142LiNWangPWangXGengCChenJGongY. Molecular diagnosis of COVID-19: Current situation and trend in China (Review). . 2020Nov;20(5):13. https://doi.org/10.3892/etm.2020.9142Search in Google Scholar
Lipsitch M, Grad YH, Sette A, Crotty S. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol. 2020 Nov;20(11):709–713. https://doi.org/10.1038/s41577-020-00460-4LipsitchMGradYHSetteACrottyS. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. . 2020Nov;20(11):709–713. https://doi.org/10.1038/s41577-020-00460-4Search in Google Scholar
Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Feng Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020a Jun;505:172–175. https://doi.org/10.1016/j.cca.2020.03.009LiuRHanHLiuFLvZWuKLiuYFengYZhuC. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. . 2020aJun;505:172–175. https://doi.org/10.1016/j.cca.2020.03.009Search in Google Scholar
Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, Wang Q, Tan L, Wu W, Tang S, et al. Evaluation of nucleocapsid and spike proteinbased enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020b May;58(6):10.1128/ jcm.00461-20. https://doi.org/10.1128/jcm.00461-20LiuWLiuLKouGZhengYDingYNiWWangQTanLWuWTangSet al.Evaluation of nucleocapsid and spike proteinbased enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. . 2020bMay;58(6): 10.1128/ jcm.00461-20. https://doi.org/10.1128/jcm.00461-20Search in Google Scholar
Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020 Aug;26(8):1200–1204. https://doi.org/10.1038/s41591-020-0965-6LongQXTangXJShiQLLiQDengHJYuanJHuJLXuWZhangYLvFJet al.Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. . 2020Aug;26(8):1200–1204. https://doi.org/10.1038/s41591-020-0965-6Search in Google Scholar
Lv H, Wu NC, Tsang OT, Yuan M, Perera RAPM, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH, et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. 2020 Jun;31(9):107725. https://doi.org/10.1016/j.celrep.2020.107725LvHWuNCTsangOTYuanMPereraRAPMLeungWSSoRTYChanJMCYipGKChikTSHet al.Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. . 2020Jun;31(9):107725. https://doi.org/10.1016/j.celrep.2020.107725Search in Google Scholar
Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, Cheng L, Li Y, Ma X, Jin T. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020 Jul;17(7):773 –775. https://doi.org/10.1038/s41423-020-0474-zMaHZengWHeHZhaoDJiangDZhouPChengLLiYMaXJinT. Serum IgA, IgM, and IgG responses in COVID-19. . 2020Jul;17(7):773–775.https://doi.org/10.1038/s41423-020-0474-zSearch in Google Scholar
Masiá M, Telenti G, Fernández M, García JA, Agulló V, Padilla S, García-Abellán J, Guillén L, Mascarell P, Asenjo JC, et al. SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: Viral load predicts antibody response. Open Forum Infect Dis. 2021 Jan 5;8(2):ofab005. https://doi.org/10.1093/ofid/ofab005MasiáMTelentiGFernándezMGarcíaJAAgullóVPadillaSGarcía-AbellánJGuillénLMascarellPAsenjoJCet al.SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: Viral load predicts antibody response. . 2021Jan5;8(2):ofab005. https://doi.org/10.1093/ofid/ofab005Search in Google Scholar
Montesinos I, Gruson D, Kabamba B, Dahma H, Van den Wijn-gaert S, Reza S, Carbone V, Vandenberg O, Gulbis B, Wolff F, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020 Jul;128:104413. https://doi.org/10.1016/j.jcv.2020.104413MontesinosIGrusonDKabambaBDahmaH Van den Wijn-gaertSRezaSCarboneVVandenbergOGulbisBWolffFet al.Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. . 2020Jul;128:104413. https://doi.org/10.1016/j.jcv.2020.104413Search in Google Scholar
Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol. 2020 Aug;129:104511. https://doi.org/10.1016/j.jcv.2020.104511NicolTLefeuvreCSerriOPivertAJoubaudFDubéeVKouatchetADucancelleALunel-FabianiFLe Guillou-GuillemetteH. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). . 2020Aug;129:104511. https://doi.org/10.1016/j.jcv.2020.104511Search in Google Scholar
Nuccetelli M, Pieri M, Gisone F, Bernardini S. Combined anti-SARS-CoV-2 IgA, IgG, and IgM detection as a better strategy to prevent second infection spreading waves. Immunol Invest. 2022 Feb;51(2):233–245. https://doi.org/10.1080/08820139.2020.1823407NuccetelliMPieriMGisoneFBernardiniS. Combined anti-SARS-CoV-2 IgA, IgG, and IgM detection as a better strategy to prevent second infection spreading waves. . 2022Feb;51(2):233–245. https://doi.org/10.1080/08820139.2020.1823407Search in Google Scholar
Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K, Deakin CT. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020 Dec;11(1):6317. https://doi.org/10.1038/s41467-020-19741-6PeckhamHdeGruijterNMRaineCRadziszewskaACiurtinCWedderburnLRRosserECWebbKDeakinCT. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. . 2020Dec;11(1):6317. https://doi.org/10.1038/s41467-020-19741-6Search in Google Scholar
Peeling RW, Wedderburn CJ, Garcia PJ, Boeras D, Fongwen N, Nkengasong J, Sall A, Tanuri A, Heymann DL. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis. 2020 Sep;20(9):e245–e249. https://doi.org/10.1016/S1473-3099(20)30517-XPeelingRWWedderburnCJGarciaPJBoerasDFongwenNNkengasongJSallATanuriAHeymannDL. Serology testing in the COVID-19 pandemic response. . 2020Sep;20(9):e245–e249. https://doi.org/10.1016/S1473-3099(20)30517-XSearch in Google Scholar
Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020 Apr;395(10230):1101–1102. https://doi.org/10.1016/S0140-6736(20)30788-1PetherickA. Developing antibody tests for SARS-CoV-2. . 2020Apr;395(10230):1101–1102. https://doi.org/10.1016/S0140-6736(20)30788-1Search in Google Scholar
Pieri M, Ciotti M, Carlozzi N, Frassanito ML, Meloni A, Cistera A, Turchetti G, Niscola S, Labate G, Calugi G, et al. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Clin Chim Acta. 2020 Dec;511:28–32. https://doi.org/10.1016/j.cca.2020.09.033PieriMCiottiMCarlozziNFrassanitoMLMeloniACisteraATurchettiGNiscolaSLabateGCalugiGet al.SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. . 2020Dec;511:28–32. https://doi.org/10.1016/j.cca.2020.09.033Search in Google Scholar
Pisanic N, Randad PR, Kruczynski K, Manabe YC, Thomas DL, Pekosz A, Klein SL, Betenbaugh MJ, Clarke WA, Laeyendecker O, et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J Clin Microbiol. 2020 Dec;59(1): 10.1128/jcm.02204-20. https://doi.org/10.1128/jcm.02204-20PisanicNRandadPRKruczynskiKManabeYCThomasDLPekoszAKleinSLBetenbaughMJClarkeWALaeyendeckerOet al.COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. . 2020Dec;59(1):10.1128/jcm.02204-20. https://doi.org/10.1128/jcm.02204-20Open DOISearch in Google Scholar
Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, Zhu Q, Liu L. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Nov;71(16):2255–2258. https://doi.org/10.1093/cid/ciaa489QuJWuCLiXZhangGJiangZLiXZhuQLiuL. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). . 2020Nov;71(16):2255–2258. https://doi.org/10.1093/cid/ciaa489Search in Google Scholar
Sadiq S, Khan M, Sadiq T, Orakzai S, Dawood MM, Haq NU, Riaz N. Impact of age, gender, post infection and post vaccination status on antibody response in COVID 19 patients. J Pak Med Assoc. 2022 Sep;72(9):1805–1809. https://doi.org/10.47391/jpma.5309SadiqSKhanMSadiqTOrakzaiSDawoodMMHaqNURiazN. Impact of age, gender, post infection and post vaccination status on antibody response in COVID 19 patients. . 2022Sep;72(9):1805–1809. https://doi.org/10.47391/jpma.5309Search in Google Scholar
Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, Hemmings O, O’Byrne A, Kouphou N, Galao RP, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 Dec;5(12):1598–1607. https://doi.org/10.1038/s41564-020-00813-8SeowJGrahamCMerrickBAcorsSPickeringSSteelKJAHemmingsOO’ByrneAKouphouNGalaoRPet al.Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. . 2020Dec;5(12):1598–1607. https://doi.org/10.1038/s41564-020-00813-8Search in Google Scholar
Sharma S, Shrivastava S, Kausley SB, Rai B, Pandit AB. Coronavirus: A comparative analysis of detection technologies in the wake of emerging variants. Infection. 2023 Feb;51(1):1–19. https://doi.org/10.1007/s15010-022-01819-6SharmaSShrivastavaSKausleySBRaiBPanditAB. Coronavirus: A comparative analysis of detection technologies in the wake of emerging variants. . 2023Feb;51(1):1–19. https://doi.org/10.1007/s15010-022-01819-6Search in Google Scholar
Shi AC, Ren P. SARS-CoV-2 serology testing: Progress and challenges. J Immunol Methods. 2021 Jul;494:113060. https://doi.org/10.1016/j.jim.2021.113060ShiACRenP. SARS-CoV-2 serology testing: Progress and challenges. . 2021Jul;494:113060. https://doi.org/10.1016/j.jim.2021.113060Search in Google Scholar
Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claёr L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021 Jan;13(577):eabd2223. https://doi.org/10.1126/scitranslmed.abd2223SterlinDMathianAMiyaraMMohrAAnnaFClaёrLQuentricPFadlallahJDevilliersHGhillaniPet al.IgA dominates the early neutralizing antibody response to SARS-CoV-2. . 2021Jan;13(577):eabd2223. https://doi.org/10.1126/scitranslmed.abd2223Search in Google Scholar
Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, Xiong F, Sun X, Song CX, Xiang CG, et al. Serologic detection of SARS-CoV-2 infections in hemodialysis centers: A multicenter retrospective study in Wuhan, China. Am J Kidney Dis. 2020a Oct;76(4):490–499.e1. https://doi.org/10.1053/j.ajkd.2020.06.008TangHTianJBDongJWTangXTYanZYZhaoYYXiongFSunXSongCXXiangCGet al.Serologic detection of SARS-CoV-2 infections in hemodialysis centers: A multicenter retrospective study in Wuhan, China. . 2020aOct;76(4):490–499.e1. https://doi.org/10.1053/j.ajkd.2020.06.008Search in Google Scholar
Tang MS, Hock KG, Logsdon NM, Hayes JE, Gronowski AM, Anderson NW, Farnsworth CW. Clinical performance of the Roche SARS-CoV-2 serologic assay. Clin Chem. 2020b Aug;66(8):1107–1109. https://doi.org/10.1093/clinchem/hvaa132TangMSHockKGLogsdonNMHayesJEGronowskiAMAndersonNWFarnsworthCW. Clinical performance of the Roche SARS-CoV-2 serologic assay. . 2020bAug;66(8):1107–1109. https://doi.org/10.1093/clinchem/hvaa132Search in Google Scholar
Tariq M, Hur J, Seo JW, Kim DY, Yun NR, Lee YM, Bang MS, Hwang SY, Kim CM, Lee JH, et al. Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2. Microbiol Spectr. 2021 Dec;9(3):e0067221. https://doi.org/10.1128/spectrum.00672-21TariqMHurJSeoJWKimDYYunNRLeeYMBangMSHwangSYKimCMLeeJHet al.Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2. . 2021Dec;9(3):e0067221. https://doi.org/10.1128/spectrum.00672-21Search in Google Scholar
Theel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The role of antibody testing for SARS-CoV-2: Is there one? J Clin Microbiol. 2020 Jul;58(8):10.1128/jcm.00797-20. https://doi.org/10.1128/jcm.00797-20TheelESSlevPWheelerSCouturierMRWongSJKadkhodaK. The role of antibody testing for SARS-CoV-2: Is there one?. 2020Jul;58(8):10.1128/jcm.00797-20. https://doi.org/10.1128/jcm.00797-20Search in Google Scholar
Tré-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogné JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 Feb;93(2):803–811. https://doi.org/10.1002/jmv.26303Tré-HardyMWilmetABeukingaIFavresseJ Dogné JM, DouxfilsJBlaironL. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. . 2021Feb;93(2):803–811. https://doi.org/10.1002/jmv.26303Search in Google Scholar
Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW. Diagnosing COVID-19: The disease and tools for detection. ACS Nano. 2020 Apr;14(4):3822–3835. https://doi.org/10.1021/acsnano.0c02624UdugamaBKadhiresanPKozlowskiHNMalekjahaniAOsborneMLiVYCChenHMubarekaSGubbayJBChanWCW. Diagnosing COVID-19: The disease and tools for detection. . 2020Apr;14(4):3822–3835. https://doi.org/10.1021/acsnano.0c02624Search in Google Scholar
Van Elslande J, Decru B, Jonckheere S, Van Wijngaerden E, Houben E, Vandecandelaere P, Indevuyst C, Depypere M, Desmet S, André E, et al. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin Microbiol Infect. 2020 Nov;26(11):1557.e1–1557.e7. https://doi.org/10.1016/j.cmi.2020.07.038VanElslandeJDecruBJonckheereSVanWijngaerdenEHoubenEVandecandelaerePIndevuystCDepypereMDesmetSAndréEet al.Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. . 2020Nov;26(11):1557.e1–1557.e7. https://doi.org/10.1016/j.cmi.2020.07.038Search in Google Scholar
Verkerke H, Horwath M, Saeedi B, Boyer D, Allen JW, Owens J, Arthur CM, Nakahara H, Rha J, Patel K, et al. Comparison of antibody class-specific SARS-CoV-2 serologies for the diagnosis of acute COVID-19. J Clin Microbiol. 2021 Mar;59(4):10.1128/jcm.02026-20. https://doi.org/10.1128/jcm.02026-20VerkerkeHHorwathMSaeediBBoyerDAllenJWOwensJArthurCMNakaharaHRhaJPatelKet al.Comparison of antibody class-specific SARS-CoV-2 serologies for the diagnosis of acute COVID-19. . 2021Mar;59(4):10.1128/jcm.02026-20. https://doi.org/10.1128/jcm.02026-20Open DOISearch in Google Scholar
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr;181(2):281–292.e6. https://doi.org/10.1016/j.celL2020.02.058WallsACParkYJTortoriciMAWallAMcGuireATVeeslerD. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. . 2020Apr;181(2):281–292.e6. https://doi.org/10.1016/j.celL2020.02.058Search in Google Scholar
Wang P. Significance of IgA antibody testing for early detection of SARS-CoV-2. J Med Virol. 2021 Apr;93(4):1888–1889. https://doi.org/10.1002/jmv.26703WangP. Significance of IgA antibody testing for early detection of SARS-CoV-2. . 2021Apr;93(4):1888–1889. https://doi.org/10.1002/jmv.26703Search in Google Scholar
Wang Q, Du Q, Guo B, Mu D, Lu X, Ma Q, Guo Y, Fang L, Zhang B, Zhang G, et al. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays. J Clin Microbiol. 2020 May;58(6):10.1128/ jcm.00375-20. https://doi.org/10.1128/jcm.00375-20WangQDuQGuoBMuDLuXMaQGuoYFangLZhangBZhangGet al.A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays. . 2020May;58(6):10.1128/ jcm.00375-20. https://doi.org/10.1128/jcm.00375-20Open DOISearch in Google Scholar
Watson J, Richter A, Deeks J. Testing for SARS-CoV-2 antibodies. BMJ. 2020 Sep;370:m3325. https://doi.org/10.1136/bmj.m3325WatsonJRichterADeeksJ. Testing for SARS-CoV-2 antibodies. . 2020Sep;370:m3325. https://doi.org/10.1136/bmj.m3325Search in Google Scholar
Xu M, O’Brien MP, Hooper AT, Forleo-Neto E, Isa F, Hou P, Chan KC, Cohen MS, Marovich MA, Hamilton JD, et al. Nasopharyngeal viral load is the major driver of incident antibody immune response to SARS-CoV-2 infection. Open Forum Infect Dis. 2023 Dec;10(12):ofad598. https://doi.org/10.1093/ofid/ofad598XuMO’BrienMPHooperATForleo-NetoEIsaFHouPChanKCCohenMSMarovichMAHamiltonJDet al.Nasopharyngeal viral load is the major driver of incident antibody immune response to SARS-CoV-2 infection. . 2023Dec;10(12):ofad598. https://doi.org/10.1093/ofid/ofad598Search in Google Scholar
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 Aug;56(2):2001526. https://doi.org/10.1183/13993003.01526-2020YuHQSunBQFangZFZhaoJCLiuXYLiYMSunXZLiangHFZhongBHuangZFet al.Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. . 2020Aug;56(2):2001526. https://doi.org/10.1183/13993003.01526-2020Search in Google Scholar
Zervou FN, Louie P, Stachel A, Zacharioudakis IM, Ortiz-Mendez Y, Thomas K, Aguero-Rosenfeld ME. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021 Sep;93(9):5409–5415. https://doi.org/10.1002/jmv.27058ZervouFNLouiePStachelAZacharioudakisIMOrtiz-MendezYThomasKAguero-RosenfeldME. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. . 2021Sep;93(9):5409–5415. https://doi.org/10.1002/jmv.27058Search in Google Scholar
Zhai B, Clarke K, Bauer DL, Moehling Geffel KK, Kupul S, Schratz LJ, Nowalk MP, McElroy AK, McLachlan JB, Zimmerman RK, et al. SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients. J Immunol. 2022 Apr;208(7):1711–1718. https://doi.org/10.4049/jimmunol.2101156ZhaiBClarkeKBauerDLMoehlingGeffelKKKupulSSchratzLJNowalkMPMcElroyAKMcLachlanJBZimmermanRKet al.SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients. . 2022Apr;208(7):1711–1718. https://doi.org/10.4049/jimmunol.2101156Search in Google Scholar
Zhang J, Xiao T, Cai Y, Chen B. Structure of SARS-CoV-2 spike protein. Curr Opin Virol. 2021 Oct;50:173–182. https://doi.org/10.1016/j.coviro.2021.08.010ZhangJXiaoTCaiYChenB. Structure of SARS-CoV-2 spike protein. . 2021Oct;50:173–182. https://doi.org/10.1016/j.coviro.2021.08.010Search in Google Scholar
Zhang S, Wang L, Cheng G. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. Mol Ther. 2022 May;30(5):1869–1884. https://doi.org/10.1016/j.ymthe.2022.02.014ZhangSWangLChengG. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. . 2022May;30(5):1869–1884. https://doi.org/10.1016/j.ymthe.2022.02.014Search in Google Scholar
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020 Nov;71(16):2027–2034. https://doi.org/10.1093/cid/ciaa344ZhaoJYuanQWangHLiuWLiaoXSuYWangXYuanJLiTLiJet al.Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. . 2020Nov;71(16):2027–2034. https://doi.org/10.1093/cid/ciaa344Search in Google Scholar
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLet al.A pneumonia outbreak associated with a new coronavirus of probable bat origin. . 2020Mar;579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7Search in Google Scholar